Skip to main content
Premium Trial:

Request an Annual Quote

High Throughput Genomics Pockets $1.2M in Series A Round

NEW YORK, Jan. 21 - High Throughput Genomics on Monday said it has collected $1.25M in a Series A round of private-equity financing.

The Tucson, Ariz.-based startup said it will spend the cash, put up by investment firms Solstice Capital and Tucson Ventures, to help deploy its Multiplexed Molecular Profiling high-throughput-analysis technology. That technology analyses DNA, mRNA, and protein expression in drug discovery, development, and diagnostics applications, according to High Throughput Genomics.

"The investment will enable HTG to more effectively market its technology to the pharmaceutical research and diagnostics industry, develop and introduce additional products, and also allow HTG to expand its own efforts in drug discovery and diagnostics in collaboration with the Arizona Cancer Center and other leading groups in academia and industry," Bruce Seligmann, founder and chief executive officer of HTG, said in a statement.

Larry Aldrich, co-managing director and founder of Tucson Ventures, said in the statement: "Our investment in HTG ... demonstrates our belief that biotechnology will be a major industry in Tucson and Arizona over the next decade." The financing represents Tucson Ventures' maiden investment, he said.

Jim Thornton, another of Tucson Ventures' co-managing directors added that the investment meant to "underscore how the areas of genomics and proteomics can become key economic drivers for the local and state economy [in Phoenix] over the next decade." 

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.